- Presentations
- 4
- Markets
- 1
Niktimvo is a brand of Axatilimab marketed by Incyte, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Axatilimab
- Brand owner
- Incyte
- Registered in
- United States
- Strengths and forms
- 22 mg/0.44 mL injection, 22 mg/2.2 mL injection, 9 mg/0.18 mL injection, 9 mg/0.9 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Niktimvo 22 mg/0.44 mL injectionIntravenous Cold chain | Incyte | US FDA | Available on request |
| Niktimvo 22 mg/2.2 mL injectionIntravenous Cold chain | Incyte | US FDA | Available on request |
| Niktimvo 9 mg/0.18 mL injectionIntravenous Cold chain | Incyte | US FDA | Available on request |
| Niktimvo 9 mg/0.9 mL injectionIntravenous Cold chain | Incyte | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Niktimvo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.